Klaus Brusgaard

Search results

• Comparison of NGS Platforms & Software

  Klaus Brusgaard (Lecturer)

  6. Nov 2013

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Molecular Genetics in Oncology

  Klaus Brusgaard (Lecturer)

  19. Apr 2013

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Molecular Genetic testing in a Clinical Setting

  Klaus Brusgaard (Lecturer)

  18. Apr 2013

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Inherited breast and ovary cancers: Lunch time meeting with the geneticist

  Klaus Brusgaard (Lecturer)

  23. Nov 2012

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Congenital Hyperinsulinismand Monogenic diabetes

  Klaus Brusgaard (Lecturer)

  28. Mar 2012

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Congenital Hyperinsulinism and Monogenic Diabetes

  Klaus Brusgaard (Lecturer)

  28. Feb 2012

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Prevalence of activating glucokinase mutations and a novel mutation.

  Klaus Brusgaard (Lecturer)

  20. Sept 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Functional analysis of Beta-cell mutations in congenital hyperinsulinism and neonatal diabetes: A new heterozygote model

  Klaus Brusgaard (Lecturer)

  24. Aug 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Genetic Variants and Phenotypic Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM)

  Klaus Brusgaard (Speaker)

  9. May 2008 → 11. May 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• No mutations in uncoupling protein 2 in a large series of genitically unexplained congenital hyperinsulinism

  Klaus Brusgaard (Speaker)

  1. Nov 2006 → 4. Nov 2006

  Activity: Talks and presentations › Talks and presentations in private or public companies

• A TCF-1 mutation may cause transient congenital hyperinsulinism followed by MODY 3

  Klaus Brusgaard (Speaker)

  2006

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Non-insulinoma pancreatigenous hypoglycaemia syndroma (NIPHS) caused by an activating glucokinase mutation

  Klaus Brusgaard (Speaker)

  2006

  Activity: Talks and presentations › Talks and presentations in private or public companies